Inspiration Healthcare Group (LSE:IHC) Research & Development: £0.00 Mil (TTM As of Jan. 2026)


LSE:IHC Inspiration Healthcare Group PLC LSE:IHC
48 GF Score
Price £0.23
GF Value £0.22
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Inspiration Healthcare Group Research & Development?

Inspiration Healthcare Group LSE:IHC 48 Research & Development is £0.00 Mil as of Jan. 2026. GuruFocus rates LSE:IHC with a GF Score™ of 48/100 and a GF Value™ of £0.22 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Inspiration Healthcare Group's Research & Development for the six months ended in Jan. 2026 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 was £0.00 Mil.

Inspiration Healthcare Group  (LSE:IHC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Inspiration Healthcare Group Research & Development Related Terms

Inspiration Healthcare Group Research & Development Historical Data

* Premium members only.

The historical data trend for Inspiration Healthcare Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inspiration Healthcare Group Research & Development Chart

Inspiration Healthcare Group Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.35 0.12 0.12 0.25 0.00

Inspiration Healthcare Group Semi-Annual Data
Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:IHC
48GF Score
Inspiration Healthcare Group PLC LSE:IHC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inspiration Healthcare Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.00 Mil mean?
Inspiration Healthcare Group (LSE:IHC) has a Research & Development of £0.00 Mil as of Jan. 2026. Research and development expense is the total cost for research and development activities. View historical data on Inspiration Healthcare Group and its competitors.
Is Inspiration Healthcare Group's Research & Development too high?
Inspiration Healthcare Group's current Research & Development is £0.00 Mil. Overall, Inspiration Healthcare Group has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Inspiration Healthcare Group's Research & Development compare to ABT and SYK?
Inspiration Healthcare Group's Research & Development of £0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Inspiration Healthcare Group and its competitors. Inspiration Healthcare Group's current Research & Development is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspiration Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Inspiration Healthcare Group (LSE:IHC) is currently considered Fairly Valued. The stock's GF Value™ is £0.22, compared to a current price of £0.23 — trading 2.3% above its estimated fair value. The current Research & Development is £0.00 Mil. Inspiration Healthcare Group's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Inspiration Healthcare Group (LSE:IHC), the current Research & Development is £0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inspiration Healthcare Group (LSE:IHC) Overvalued in 2026?

Based on GuruFocus' analysis, Inspiration Healthcare Group stock appears to be overvalued. The current stock price of £0.23 is trading 2.3% above its estimated GF Value™ of £0.22. GuruFocus considers Inspiration Healthcare Group to be Fairly Valued.

Key valuation signals for LSE:IHC:

  • Research & Development: £0.00 Mil
  • GF Value™: £0.22 vs. price of £0.23 (2.3% above fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the LSE:IHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Inspiration Healthcare Group Business Description

Address Unit 7/8 Commerce Park, Commerce Way, Croydon, GBR, CR0 4YL
Inspiration Healthcare Group PLC supplies outcome-improving medical devices in the areas of neonatal intensive care and patient warming. It operates in the Critical Care Medical Devices segment which includes Critical Care, Operating Theatre, and Home Healthcare. The company derives the maximum of its revenue from the United Kingdom through the Critical Care market division.
48GF Score

Get the complete analysis for LSE:IHC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.23
Price
£0.22
GF Value